{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:15:51Z","timestamp":1786994151157,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.metabol.2013.07.002","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T15:16:21Z","timestamp":1376579781000},"page":"1577-1586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: A metabolomics analysis"],"prefix":"10.1016","volume":"62","author":[{"given":"Takafumi","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Katsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Okumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Nishise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisayoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyoshi","family":"Soga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2013.07.002_bb0005","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/hep.1840140603","article-title":"Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis","volume":"14","author":"Di Bisceglie","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2013.07.002_bb0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.1840120409","article-title":"Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus","volume":"12","author":"Kiyosawa","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2013.07.002_bb0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-129-2-199807150-00005","article-title":"Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group","volume":"129","author":"Imai","year":"1998","journal-title":"Ann Intern Med"},{"issue":"10 Suppl 2","key":"10.1016\/j.metabol.2013.07.002_bb0020","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/S1542-3565(05)00713-5","article-title":"Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy","volume":"3","author":"Omata","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2013.07.002_bb0025","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2010.11.050","article-title":"Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C","volume":"140","author":"Lok","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2013.07.002_bb0030","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1872-034X.2011.00847.x","article-title":"Cancer preventive effect of pegylated interferon \u03b1-2b plus ribavirin in a real-life clinical setting in Japan: PERFECT interim analysis","volume":"41","author":"Watanabe","year":"2011","journal-title":"Hepatol Res"},{"key":"10.1016\/j.metabol.2013.07.002_bb0035","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1872-034X.2012.00984.x","article-title":"Effects of interferon therapy on development of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. A meta-analysis of randomized controlled trials","volume":"42","author":"Qu","year":"2012","journal-title":"Hepatol Res"},{"issue":"Suppl 1","key":"10.1016\/j.metabol.2013.07.002_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1440-1746.2010.06592.x","article-title":"Reactive oxygen and mechanisms of inflammatory liver injury: present concepts","volume":"26","author":"Jaeschke","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2013.07.002_bb0045","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.freeradbiomed.2012.01.008","article-title":"Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic considerations","volume":"52","author":"Choi","year":"2012","journal-title":"Free Radic Biol Med"},{"issue":"Suppl 1","key":"10.1016\/j.metabol.2013.07.002_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000333253","article-title":"Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species","volume":"81","author":"Fujinaga","year":"2011","journal-title":"Oncology"},{"key":"10.1016\/j.metabol.2013.07.002_bb0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2407-12-177","article-title":"Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma","volume":"12","author":"Romilda","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.metabol.2013.07.002_bb0060","doi-asserted-by":"crossref","first-page":"15271","DOI":"10.3390\/ijms131115271","article-title":"Role of oxidative stress in hepatocarcinogenesis induced by hepatitis C virus","volume":"13","author":"Tsukiyama-Kohara","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2013.07.002_bb0065","doi-asserted-by":"crossref","first-page":"16768","DOI":"10.1074\/jbc.M601876200","article-title":"Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption","volume":"281","author":"Soga","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2013.07.002_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/hep.22604","article-title":"Cystathionine beta-synthase as a carbon monoxide-sensitive regulator of bile excretion","volume":"49","author":"Shintani","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2013.07.002_bb0075","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2011.01.031","article-title":"Serum metabolomics reveals \u03b3-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease","volume":"55","author":"Soga","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2013.07.002_bb0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/20014091084227","article-title":"Gamma glutamyl transferase","volume":"38","author":"Whitfield","year":"2001","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.metabol.2013.07.002_bb0085","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11306-009-0178-y","article-title":"Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles","volume":"6","author":"Sugimoto","year":"2010","journal-title":"Metabolomics"},{"key":"10.1016\/j.metabol.2013.07.002_bb0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/157489312799304431","article-title":"Bioinformatics tools for mass spectroscopy-based metabolomic data processing and analysis","volume":"7","author":"Sugimoto","year":"2012","journal-title":"Curr Bioinform"},{"key":"10.1016\/j.metabol.2013.07.002_bb0095","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11306-010-0270-3","article-title":"Bioinformatics tools for cancer metabolomics","volume":"7","author":"Blekherman","year":"2011","journal-title":"Metabolomics"},{"key":"10.1016\/j.metabol.2013.07.002_bb0100","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1186\/1471-2105-11-571","article-title":"Probabilistic principal component analysis for metabolomic data","volume":"11","author":"Nyamundanda","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.metabol.2013.07.002_bb0105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2013.07.002_bb0110","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2013.07.002_bb0115","first-page":"715","article-title":"Enzymes of the kynurenine pathway","volume":"55","author":"Tankiewicz","year":"2001","journal-title":"Postepy Hig Med Dosw"},{"key":"10.1016\/j.metabol.2013.07.002_bb0120","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1042\/BST0361120","article-title":"Exploring the mechanism of tryptophan 2,3-dioxygenase","volume":"36","author":"Thackray","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.metabol.2013.07.002_bb0125","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1096\/fasebj.5.11.1907934","article-title":"Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism","volume":"5","author":"Taylor","year":"1991","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2013.07.002_bb0130","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2174\/0929867033457179","article-title":"Interferon-\u03b3-induced conversion of tryptophan: immunologic and neuropsychiatric aspects","volume":"10","author":"Wirleitner","year":"2003","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.metabol.2013.07.002_bb0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00702-011-0681-y","article-title":"The kynurenine system and immunoregulation","volume":"119","author":"M\u00e1ndi","year":"2012","journal-title":"J Neural Transm"},{"key":"10.1016\/j.metabol.2013.07.002_bb0140","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0900408","article-title":"Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression","volume":"183","author":"Liu","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2013.07.002_bb0145","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/138920007780362536","article-title":"Implications of IFN-gamma-mediated tryptophan catabolism on solid organ transplantation","volume":"8","author":"Brandacher","year":"2007","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.metabol.2013.07.002_bb0150","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.metabol.2012.05.004","article-title":"SNPs affecting serum metabolomic traits may regulate gene transcription and lipid accumulation in the liver","volume":"61","author":"Mirkov","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.07.002_bb0155","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1016\/S0021-9258(18)35980-5","article-title":"Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine)","volume":"254","author":"Griffith","year":"1979","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2013.07.002_bb0160","first-page":"516","article-title":"Depletion of glutathione in the kidney and the renal disposition of administered inorganic mercury","volume":"25","author":"Zalups","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.metabol.2013.07.002_bb0165","first-page":"888","article-title":"gamma-Glutamyl transpeptidase as a response predictor when using alpha-interferon to treat hepatitis C","volume":"42","author":"Van Thiel","year":"1995","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.metabol.2013.07.002_bb0170","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1478-3231.2007.01540.x","article-title":"\u03b3-Glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-\u03b1-2b in chronic hepatitis C non-responders","volume":"27","author":"Bergmann","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2013.07.002_bb0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2893.2005.00579.x","article-title":"Gamma-glutamyltransferase in fine-needle liver biopsies of subjects with chronic hepatitis C","volume":"12","author":"Paolicchi","year":"2005","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.metabol.2013.07.002_bb0180","doi-asserted-by":"crossref","first-page":"40409","DOI":"10.1074\/jbc.R110.182451","article-title":"Endogenous ligands for nuclear receptors: digging deeper","volume":"285","author":"Schupp","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2013.07.002_bb0185","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1021\/cr2001355","article-title":"PPARs and lipid ligands in inflammation and metabolism","volume":"111","author":"Harmon","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.metabol.2013.07.002_bb0195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1479-5876-9-171","article-title":"Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview","volume":"9","author":"Marra","year":"2011","journal-title":"J Transl Med"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513002199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513002199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:02:25Z","timestamp":1758427345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049513002199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0026049513002199"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2013.07.002","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: A metabolomics analysis","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2013.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}